Global Business, Science & Technology News Source
Health News
Large and Innovative Pipeline Analysis has confirmed the asthma pipeline to be highly active, with 252 products in active development across all stages. The range of mechanisms of action employed …
Asthma research and market – Identifying and Commercializing First-in-Class Innovation Read MoreResearch, the leading business intelligence provider, has released its latest research, “”Rheumatoid Arthritis Therapeutics in Asia-Pacific Markets to 2021 – Novel IL-6 and JAK Inhibitors to Stimulate Moderate Growth Despite …
Rheumatoid Arthritis Therapeutics in Asia-Pacific Market is expected to register at a CAGR of 3.3% by 2021 Read MoreResearch’s latest report “Contract Research Organization Market: Global Deals and Operational Strategies” discusses the deal making activity during the past five years and in-depth analysis of the key deals involving …
Global Contract Research Organization(CRO) Market size,share, trends, growth, analysis, industry research report, Deals and Operational Strategies Read MorePancreatic cancer is the 12th most common cancer globally, and the fourth most fatal, with a mortality rate of 10.9 deaths per 100,000 people per year. The poor prognosis of …
Global Research on Pancreatic Cancer – Identifying and Commercializing First-in-Class Innovation: Market size, share, trends, growth and analysis report Read MoreRheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone erosion over many years, and …
Analyst’s Predicts Rheumatoid Arthritis Market Expected to grow at a CAGR of 5.2% by 2020 – A Crowded Market Characterized by Modest Growth Read MoreResearch, the leading business intelligence provider, has released its latest research: “Colorectal Cancer Therapeutics in Major Developed Markets to 2020 – Increased Uptake of High Priced Drugs to Offset the …
Colorectal Cancer (CRC) Therapeutics Market will grow at a CAGR of 5% by 2020 Read MoreResearch, a leading business intelligence provider, has released its latest research report: “Ovarian Cancer Therapeutics in Asia-Pacific Markets to 2020 – Off-patent Chemo-regimens to Retain Dominance Despite New Launches”. The …
Ovarian Cancer Therapeutics in Asia-Pacific Market revenue is forecast to rise at a limited CAGR of 5.1% by 2020 Read More